COFCO Biotechnology Co., Ltd.
000930.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.99B
Close$
$8.52
68.4% upside
Current Fair Value
68.4% upsideUndervalued by 68.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $9.99 Billion |
|---|---|
| Enterprise Value | $13.53 Billion |
| Dividend Yield | $0.03 (0.56%) |
| Earnings per Share | $0.02 |
| Beta | 0.26 |
| Outstanding Shares | 1,856,442,396 |
Return
| Return on Equity | -2.31% |
|---|---|
| Return on Assets | -1.32% |
| Return on Invested Capital | -1.61% |
Valuation & Multiples
| P/E Ratio | -41.93 |
|---|---|
| PEG | 24.42 |
| Price to Sales | 0.56 |
| Price to Book Ratio | 1.01 |
| Enterprise Value to Revenue | 0.8 |
| Enterprise Value to EBIT | -67.97 |
| Enterprise Value to Net Income | -57 |
| Total Debt to Enterprise | 0.42 |
| Debt to Equity | 0.55 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 27, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 24, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About COFCO Biotechnology Co., Ltd.
4,832 employees
CEO: De Guo Zhang COFCO Biotechnology Co., Ltd., established in 1998 and headquartered in Bengbu, China, specializes in the comprehensive processing and manufacturing of agricultural products across China. Its extensive product portfolio includes a variet...